Abstract
Hypertension increases the risk of reinfarction and sudden death in post-myocardial infarction (Ml) patients. The same is true of coexisting left ventricular hypertrophy. Fortunately, these two risk factors may be modified by pharmacotherapy. In this article, Dr Boden describes the complementary use of beta blockers and selected calcium channel blockers for secondary prevention after acute Ml, particularly in the subset of patients who also have hypertension.